![Listen to Gynecologic Oncology artwork](https://is3-ssl.mzstatic.com/image/thumb/Podcasts113/v4/19/58/c9/1958c927-82f8-2fc4-afd7-4bbc74fb2ec3/mza_12896527856230623138.jpg/100x100bb.jpg)
Molecular Testing for Endometrial Cancer: A Society of Gynecologic Oncology Podcast
Listen to Gynecologic Oncology
English - January 05, 2023 05:15Science Health & Fitness medicine health care science and technology health national health service medical disease cancer politics diabetes Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Moderator: Kari Hacker, MD, PhD, Gynecologic Oncologist, New York University Langone Health
Speakers:
Christine Walsh, MD, MS, Gynecologic Oncologist, University of Colorado
Carolyn McCourt, MD, Gynecologic Oncologist, Washington University School of Medicine
Kari Hacker, MD, PhD, is joined by Christine Walsh, MD, MS, and Carolyn McCourt, MD, to review basic molecular classification as well as more complex biomarkers in endometrial cancer. They discuss how testing can be utilized to inform patient prognosis and to guide second line systemic treatment decisions. They also highlight several ongoing trials investigating treatment strategies based on molecular features, the results of which will help clinicians make better therapeutic decisions, resulting in better outcomes for patients with endometrial cancer. This podcast was developed by the Society of Gynecologic Oncology for Gynecologic Oncology.
Additional Resources: Molecular testing for endometrial cancer: An SGO clinical practice statement